Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today

Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 33.85% on an annualized basis producing an average annual return of 46.66%. Currently, Viking Therapeutics has a

Benzinga14:00 ET

Stifel Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95

Stifel analyst Annabel Samimy maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate of 43.2% and

Moomoo NewsJul 1 09:31 ET · Ratings

Stifel Nicolaus Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)

TipRanksJul 1 09:25 ET

Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?

Yahoo FinanceJul 1 08:15 ET

3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

Yahoo FinanceJun 30 06:53 ET

Express News | Viking Therapeutics Inc : Morgan Stanley Initiates Coverage With Overweight Rating; Target Price $105

ReutersJun 28 00:08 ET